PEGylation and Activated PEGs
High-Purity PEGs
Methoxypoly(ethylene glycol) (mPEG)
CH3O(CH2CH2O)nH
- Narrow Polydispersity
- Low Diol Content
- Consistency on a Commercial Scale
NOF is the first company to manufacture high-purity methoxypoly(ethylene glycol) (mPEG) in various molecular weights with a narrow polydispersity and a low diol content. These high-purity mPEGs have already been commercialized into several PEG drugs, such as PEG-INTERFERON and PEG-GCSF.
NOFfs mPEGs have lower levels of contaminating diol content than do competing products. As shown in Figure 1, the diol content is extremely low level compared with that of competitorsf mPEG (MW = 5000) products. In addition, the polydispersity of NOFfs mPEG is narrower than those of competing products. NOFfs activated PEGs are produced by using these high-quality mPEGs. The quality of the activated PEGs reflects the quality of the mPEG precursors.

NOF CORPORATION is the sole worldwide patent holder for these high-purity mPEGs and all their derivatives.
Patent Nos; JP 3050228, US 6455639, KR 0358276.
